Hims & Hers Health, Inc. (HIMS) vs TransMedics Group, Inc. (TMDX)

A side-by-side comparison of Hims & Hers Health, Inc. and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnHIMS vs TMDX

growth of $100 · dividends reinvested · last 7y
HIMS +180.7% (+15.9%/yr)TMDX +232.0% (+18.7%/yr)TMDX compounded faster over this window
0200400600Start $100202120232025$281$332
HIMS TMDX

HIMS vs TMDX: by the numbers

  • HIMS is the larger company ($6.24B vs $3.01B market cap).
  • TMDX is profitable (22.69% net margin) while HIMS runs a net loss (-5.51%).
  • TMDX grew revenue faster over the past five years (86.12% vs 67.47% CAGR).

Metrics side by side

Valuation

MetricHIMSTMDX
P/E ratioN/A22.53
Forward P/EN/A58.62
P/S ratio2.424.50
P/B ratio19.245.80
EV / EBITDAN/A28.81
FCF yield1.44%2.63%

Profitability

MetricHIMSTMDX
Gross margin73.84%58.69%
Operating margin4.50%12.21%
Net margin-5.51%22.69%
ROE-43.83%29.28%
ROIC-4.30%5.87%

Growth (annualized)

MetricHIMSTMDX
Revenue CAGR (5Y)67.47%86.12%
Total return CAGR (5Y)25.85%20.95%

Frequently asked

Which has grown faster, HIMS or TMDX?
Over the past five years, TMDX grew revenue faster — HIMS at a 67.47% CAGR versus TMDX at 86.12%.
Is HIMS or TMDX more profitable?
TMDX runs the higher net margin — HIMS at -5.51% versus TMDX at 22.69%.
How have HIMS and TMDX total returns compared?
Over the past 5 years, HIMS delivered 25.85% and TMDX delivered 20.95% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.